Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 5.3 GBX
Market Cap: 252.6m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

EV/EBIT
Enterprise Value to EBIT

-6.4
Current
-3.5
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-6.4
=
Enterprise Value
247.2m GBX
/
EBIT
-38.8m GBP
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-7
2-Years Forward
EV/EBIT
-10.4
3-Years Forward
EV/EBIT
-24.7

See Also

Discover More